Environmental surveillance of a circulating vaccine-derived poliovirus type 2 outbreak in Israel between 2022 and 2023:a genomic epidemiology study

被引:3
|
作者
Zuckerman, Neta S. [1 ]
Bucris, Efrat [1 ]
Morad-Eliyahu, Hagar [1 ]
Weiss, Leah [1 ]
Vasserman, Rinat [1 ]
Fratty, Ilana S. [1 ,2 ]
Aguvaev, Ira [1 ]
Cohen-Said, Zvi [1 ]
Matar, Rua [1 ]
Erster, Oran [1 ]
Shulman, Lester M. [1 ,5 ]
Yishai, Ruth [3 ]
Hecht-Sagie, Lior [4 ]
Alroy-Preis, Sharon [4 ]
Mendelson, Ella [1 ,5 ]
Lustig, Yaniv [1 ,5 ]
Sofer, Danit [1 ]
Bar-Or, Itay [1 ]
Weil, Merav [1 ]
机构
[1] Chaim Sheba Med Ctr, Minist Hlth, Publ Hlth Serv, Cent Virol Lab, IL-52621 Ramat Gan, Israel
[2] Israel Minist Hlth, Israel Ctr Dis Control, Ramat Gan, Israel
[3] Minist Hlth, Dept Labs, Publ Hlth Serv, Jerusalem, Israel
[4] Minist Hlth, Publ Hlth Serv, Jerusalem, Israel
[5] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Tel Aviv, Israel
来源
LANCET MICROBE | 2024年 / 5卷 / 10期
关键词
TRANSMISSION; ERADICATION; WORLDWIDE; PROGRESS;
D O I
10.1016/S2666-5247(24)00116-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Similarly to wild poliovirus, vaccine-derived poliovirus (VDPV) strains can cause acute fl accid paralysis, posing a considerable challenge to public health and the eradication of poliovirus. VDPV outbreaks, particularly VDPV type 2 (VDPV2), are increasing worldwide, including in high-income countries with high vaccine coverage. We aimed to conduct a comprehensive analysis of the molecular epidemiology of a widespread VDPV2 outbreak in Israel in 2022-23 - 23 using conventional polio identification fi cation techniques and whole-genome sequencing. Methods In this genomic epidemiology study, we monitored and identified fi ed poliovirus type 2 (PV2) through the surveillance of stool samples from individuals with acute fl accid paralysis and related contacts, as well as environmental surveillance of sewage samples. Environmental surveillance involved 15 routine surveillance sites and an additional 30 sites dedicated to monitoring this outbreak, covering approximately 70% of Israel's ' s population between April 1, 2022, and June 30, 2023. Additionally, we performed phylogenetic and mutation analyses using wholegenome, next-generation sequencing of PV2 isolates to identify recombination events, characterise VDPV2 lineages according to the capsid region, and establish the geographical distribution and linkage of PV2 isolates. Findings We detected 256 genetically linked samples from environmental surveillance, as well as one case of acute fl accid paralysis and four positive contacts associated with the Sabin type 2 oral vaccine strain. Most affected locations showed a high-density population of Jewish Ultra-Orthodox communities. Through high-resolution genomic characterisation and phylogenetic analysis of 202 representative sequences with complete capsid coverage, including isolates from both environmental surveillance and the case of acute fl accid paralysis, a conclusive linkage was established among all detections, confirming fi rming them to be part of a single VDPV2 outbreak. This strategy enabled the characterisation of three distinct lineages and established connections between different locations in Israel, including linking the case of acute fl accid paralysis and nearby environmental surveillance detections from the northern region with detections in the geographically distant central region. Interpretation This study highlights the role of environmental surveillance in the early detection and monitoring of poliovirus circulation, enabling a prompt public health response involving enhanced surveillance and a catch-up campaign with inactivated polio vaccine. Whole-genome sequencing offered valuable insights into the origins of the outbreak, linkage across detections, and the geographical distribution of the virus, with higher resolution than would have been possible with the standard analysis of the VP1 gene alone. Lancet Published 2024 https://doi.org/10.1016/ S2666-5247(24)00116-2 *Contributed Central Public of Center, (N H R I R Prof Prof Y I Israel Israel Gan, Department Public of (R Services, Jerusalem, MD, Public Medicine, Tel Prof Correspondence
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Preventing paralytic polio caused by vaccine-derived poliovirus type 2
    Franco-Paredes, Carlos
    Santos-Preciado, Jose I.
    Henao-Martinez, Andres F.
    Rodriguez-Morales, Alfonso J.
    Carrasco, Peter
    LANCET INFECTIOUS DISEASES, 2020, 20 (01): : 21 - 22
  • [32] Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020 q
    Darwar, Roopa
    Biya, Oladayo
    Greene, Sharon A.
    Jorba, Jaume
    Al Safadi, Mohammad
    Franka, Richard
    Wiesen, Eric
    Durry, Elias
    Pallansch, Mark A.
    VACCINE, 2023, 41 : A25 - A34
  • [33] Circulation of Type 2 Vaccine-Derived Poliovirus in China in 2018-2019
    Zhao, Hehe
    Ma, Xiaozhen
    Tang, Haishu
    Zhang, Yong
    Chen, Na
    Kaisaier, Wusiman
    Wang, Qi
    Wang, Cheng
    Zhu, Shuangli
    Qi, Qi
    Liu, Yu
    Ma, Qianli
    Yang, Qing
    Li, Junhan
    Wang, Dongyan
    Li, Xiaolei
    Xiao, Jinbo
    Zhu, Hui
    Xu, Wenbo
    Tong, Wenbin
    Yan, Dongmei
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (12):
  • [34] Halting vaccine-derived poliovirus circulation: the novel type 2 oral vaccine might not be enough
    Nyenswah, Tolbert G.
    Schue, Jessica L.
    LANCET GLOBAL HEALTH, 2023, 11 (06): : E811 - E812
  • [35] Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola
    Vinjé, J
    Gregoricus, N
    Martin, J
    Gary, HE
    Cáceres, VM
    Venczel, L
    Macadam, A
    Dobbins, JG
    Burns, C
    Wait, D
    Ko, G
    Landaverde, M
    Kew, O
    Sobsey, MD
    JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (07): : 1168 - 1175
  • [36] Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus
    Riquet, Franck B.
    Blanchard, Claire
    Jegouic, Sophie
    Balanant, Jean
    Guillot, Sophie
    Vibet, Marie-Anne
    Rakoto-Andrianarivelo, Mala
    Delpeyroux, Francis
    JOURNAL OF VIROLOGY, 2008, 82 (17) : 8927 - 8932
  • [37] Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021
    Yang, Hong
    Qi, Qi
    Zhang, Yong
    Wen, Ning
    Cao, Lei
    Liu, Yu
    Fan, Chunxiang
    Yan, Dongmei
    Zhu, Xiaoping
    Hao, Lixin
    Zhu, Shuangli
    Ma, Qianli
    Liu, Jiajie
    Ma, Chao
    Nan, Lei
    Chen, Yong
    Ma, Xiaozhen
    Chen, Na
    Deng, Kun
    Shao, Ge
    Ding, Xianxiang
    An, Zhijie
    Rodewald, Lance E.
    Li, Xiaolei
    Wang, Dongyan
    Zhu, Hui
    Wang, Huaqing
    Feng, Zijian
    Xu, Wenbo
    Zhou, Jiushun
    Yin, Zundong
    JAMA NETWORK OPEN, 2023, 6 (01) : E2249710
  • [38] Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
    Yang, CF
    Naguib, T
    Yang, SJ
    Nasr, E
    Jorba, J
    Ahmed, N
    Campagnoli, R
    van der Avoort, H
    Shimizu, H
    Yoneyama, T
    Miyamura, T
    Pallansch, M
    Kew, O
    JOURNAL OF VIROLOGY, 2003, 77 (15) : 8366 - 8377
  • [39] Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child
    Adu, Festus
    Iber, Jane
    Bukbuk, David
    Gumede, Nicksy
    Yang, Su-Ju
    Jorba, Jaume
    Campagnoli, Ray
    Sule, Waidi Folorunso
    Yang, Chen-Fu
    Burns, Cara
    Pallansch, Mark
    Harry, Tekena
    Kew, Olen
    VIRUS RESEARCH, 2007, 127 (01) : 17 - 25
  • [40] Circulating type 1 vaccine-derived poliovirus may evolve under the pressure of adenosine deaminases acting on RNA
    Liu, Yanhan
    Ma, Tengfei
    Liu, Jianzhu
    Zhao, Xiaona
    Cheng, Ziqiang
    Guo, Huijun
    Xu, Ruixue
    Wang, Shujing
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (17): : 2096 - 2099